WallStreetZenWallStreetZen

NASDAQ: XOMA
Xoma Royalty Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their XOMA stock forecasts and price targets.

Forecast return on equity

Is XOMA forecast to generate an efficient return?

Company
17.1%
Industry
76.22%
Market
343.1%
XOMA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is XOMA forecast to generate an efficient return on assets?

Company
5.71%
Industry
22.81%
XOMA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

XOMA earnings per share forecast

What is XOMA's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$1.11+36.84%
Avg 2 year Forecast
$0.21-73.85%
Avg 3 year Forecast
$1.21+49.91%
XOMA's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

XOMA revenue forecast

What is XOMA's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$50.5M+7.18%
Avg 2 year Forecast
$59.6M+26.43%
Avg 3 year Forecast
$71.3M+51.44%
XOMA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

XOMA earnings growth forecast

How is XOMA forecast to perform vs Biotechnology companies and vs the US market?

Company
-0.86%
Industry
74.1%
Market
104.59%
XOMA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
XOMA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
XOMA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

XOMA revenue growth forecast

How is XOMA forecast to perform vs Biotechnology companies and vs the US market?

Company
13.23%
Industry
289.31%
Market
58.77%
XOMA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
XOMA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

XOMA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
XOMA$31.13N/AN/A
OCGN$1.24$7.00+464.52%Strong Buy
TRDA$10.16N/AN/A
NMRA$2.28$7.40+225.27%Buy
TECX$20.98$73.33+249.54%Strong Buy
View Top Biotech Stocks

Xoma Royalty Stock Forecast FAQ

What is XOMA's earnings growth forecast for 2025-2027?

(NASDAQ: XOMA) Xoma Royalty's forecast annual earnings growth rate of -0.86% is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 74.1%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 104.59%.

Xoma Royalty's earnings in 2025 is $16,604,000.On average, 6 Wall Street analysts forecast XOMA's earnings for 2025 to be $13,725,431, with the lowest XOMA earnings forecast at $12,984,922, and the highest XOMA earnings forecast at $14,302,484. On average, 6 Wall Street analysts forecast XOMA's earnings for 2026 to be $2,622,741, with the lowest XOMA earnings forecast at -$2,391,177, and the highest XOMA earnings forecast at $8,061,400.

In 2027, XOMA is forecast to generate $15,036,802 in earnings, with the lowest earnings forecast at $8,507,192 and the highest earnings forecast at $21,843,794.

If you're new to stock investing, here's how to buy Xoma Royalty stock.

What is XOMA's revenue growth forecast for 2025-2027?

(NASDAQ: XOMA) Xoma Royalty's forecast annual revenue growth rate of 13.23% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 289.31%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.77%.

Xoma Royalty's revenue in 2025 is $47,106,000.On average, 6 Wall Street analysts forecast XOMA's revenue for 2025 to be $625,185,721, with the lowest XOMA revenue forecast at $592,209,518, and the highest XOMA revenue forecast at $650,112,908. On average, 6 Wall Street analysts forecast XOMA's revenue for 2026 to be $737,512,848, with the lowest XOMA revenue forecast at $627,043,187, and the highest XOMA revenue forecast at $845,146,780.

In 2027, XOMA is forecast to generate $883,398,185 in revenue, with the lowest revenue forecast at $795,837,264 and the highest revenue forecast at $966,067,781.

What is XOMA's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: XOMA) forecast ROA is 5.71%, which is lower than the forecast US Biotechnology industry average of 22.81%.

What is XOMA's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: XOMA) Xoma Royalty's current Earnings Per Share (EPS) is $0.81. On average, analysts forecast that XOMA's EPS will be $1.11 for 2025, with the lowest EPS forecast at $1.05, and the highest EPS forecast at $1.16. On average, analysts forecast that XOMA's EPS will be $0.21 for 2026, with the lowest EPS forecast at -$0.19, and the highest EPS forecast at $0.65. In 2027, XOMA's EPS is forecast to hit $1.21 (min: $0.69, max: $1.76).

What is XOMA's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: XOMA) forecast ROE is 17.1%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.